Endocardial fibroelastosis (Q42361): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Linked ICD 10 | |||
| Property / Linked ICD 10: I42.4 / rank | |||
Normal rank | |||
Latest revision as of 08:50, 13 August 2026
Endocardial fibroelastosis is the formation of a marked fibro-elastic thickening of the subendocardium in one or both cardiac ventricles. A disorder of fetuses and infants, secondary causes include congenital left-sided obstructive cardiac lesions, metabolic disorders, autoimmune disease (anti-Ro/anti-La antibodies), and transplacental viral infection such as mumps. Primary endocardial fibroelastosis has been linked to recessive and x-linked inheritance, such as with Barth syndrome.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | BC43.3 |
||
| English | Endocardial fibroelastosis |
Endocardial fibroelastosis is the formation of a marked fibro-elastic thickening of the subendocardium in one or both cardiac ventricles. A disorder of fetuses and infants, secondary causes include congenital left-sided obstructive cardiac lesions, metabolic disorders, autoimmune disease (anti-Ro/anti-La antibodies), and transplacental viral infection such as mumps. Primary endocardial fibroelastosis has been linked to recessive and x-linked inheritance, such as with Barth syndrome. |
Statements
CID11:BC43.3
0 references
dki-india-BC43.3
0 references
Concluído
0 references
13 August 2026
0 references
